These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2338419)
21. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis. Bergan T; Michalsen H; Malmborg AS; Pedersen SS; Pressler T; Storrøsten OT; Strandvik B Chemotherapy; 1993; 39(6):369-73. PubMed ID: 8222862 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group]. Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429 [TBL] [Abstract][Full Text] [Related]
24. Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin. Mayer M; Tophof C; Opferkuch W Infection; 1988; 16(4):225-8. PubMed ID: 3182087 [TBL] [Abstract][Full Text] [Related]
25. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044 [TBL] [Abstract][Full Text] [Related]
26. Using imipenem and cilastatin during continuous renal replacement therapy. Cotton A; Franklin BD; Brett S; Holmes A Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743 [TBL] [Abstract][Full Text] [Related]
27. Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects. Rizk ML; Rhee EG; Jumes PA; Gotfried MH; Zhao T; Mangin E; Bi S; Chavez-Eng CM; Zhang Z; Butterton JR Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311084 [TBL] [Abstract][Full Text] [Related]
28. Imipenem/cilastin dosage during acute renal failure and hemofiltration. Dehne MG; Kroh UF Intensive Care Med; 1995 Oct; 21(10):863. PubMed ID: 8557879 [No Abstract] [Full Text] [Related]
29. Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies. Huijgens PC; Ossenkoppele GJ; Weijers TF; van Loenen AC; Simoons-Smit AM; Wijermans PW; van Pampus EC; Langenhuijsen MM Eur J Haematol; 1991 Jan; 46(1):42-6. PubMed ID: 1988306 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus. Sundelof JG; Thompson R; White KM; Sasor MW; Cama L; Kropp H Antimicrob Agents Chemother; 1996 Mar; 40(3):795-8. PubMed ID: 8851616 [TBL] [Abstract][Full Text] [Related]
31. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Buckley MM; Brogden RN; Barradell LB; Goa KL Drugs; 1992 Sep; 44(3):408-44. PubMed ID: 1382937 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants]. Toyonaga Y; Sugita M; Hori M; Joh K Jpn J Antibiot; 1988 Nov; 41(11):1671-91. PubMed ID: 3210301 [TBL] [Abstract][Full Text] [Related]
33. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230 [TBL] [Abstract][Full Text] [Related]
34. [A clinical phase I study on intramuscular imipenem/cilastatin sodium]. Onishi A; Otawa M; Hara K Jpn J Antibiot; 1991 Aug; 44(8):860-76. PubMed ID: 1920812 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill. Hashimoto S; Honda M; Yamaguchi M; Sekimoto M; Tanaka Y ASAIO J; 1997; 43(1):84-8. PubMed ID: 9116359 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis. Claesson G; Eriksson M; Rogers JD Pharmacol Toxicol; 1992 Aug; 71(2):103-6. PubMed ID: 1438026 [TBL] [Abstract][Full Text] [Related]
38. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation]. Pezé P; Mounier M; Cevallos R; Denis F Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446 [TBL] [Abstract][Full Text] [Related]
39. [Imipenem/cilastatin as monotherapy in neutropenic patients with fever]. Fridrik MA; Wahl G; Grafinger-Witt E; Leisch F Wien Med Wochenschr; 1988 Nov; 138(21):548-51. PubMed ID: 3201783 [TBL] [Abstract][Full Text] [Related]
40. A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies. Leyland MJ; Bayston KF; Cohen J; Warren R; Newland AC; Bint AJ; Cefai C; White DG; Murray SA; Bareford D J Antimicrob Chemother; 1992 Dec; 30(6):843-54. PubMed ID: 1289359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]